Royal Jelly as a Strategy to Modulate Inflammation and Oxidative Stress in Patients With Systemic Arterial Hypertension

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 18, 2024

Primary Completion Date

August 31, 2025

Study Completion Date

December 20, 2025

Conditions
HypertensionCardiovascular Diseases (CVD)Inflammation
Interventions
DIETARY_SUPPLEMENT

Royal Jelly

Participants will receive 2 capsules per day, providing the dosage of 300mg of royal jelly for 2 months (8 weeks).

DIETARY_SUPPLEMENT

Placebo

The placebo group will receive 2 capsules per day (containing microcrystalline cellulose and magnesium stearate in colored gelatin capsules capable of masking the appearance of the internal content), at the same time for 2 months.

Trial Locations (1)

22260050

RECRUITING

Denise Mafra, Rio de Janeiro

All Listed Sponsors
lead

Universidade Federal Fluminense

OTHER